Measurement of problem behaviour during medication evaluations

Journal of Intellectual Disability Research : JIDR
J ZarconeMaria G Valdovinos

Abstract

The focus of this review is on methods that are currently being used to evaluate the behavioural effects of medication for individuals with intellectual disabilities. First we describe what has been identified as the ideal criteria for conducting clinical trials and how these criteria may be adapted to do less controlled evaluations. The central theme is a review of the biological measures (e.g. labs, drug levels), behavioural rating scales and direct observation measures that are often used to evaluate medication effects. Issues related to how the side effects of medication can affect behaviour will also be discussed. The importance of encouraging communication and collaboration across all systems of care and the use of socially valid measures are discussed.

References

Jan 1, 1975·Progress in Biophysics and Molecular Biology·G Roy
Sep 1, 1992·Journal of Autism and Developmental Disorders·E C Marshburn, M G Aman
Jul 1, 1992·The Annals of Pharmacotherapy·D M CorsoJ F Gallelli
Jan 1, 1991·Research in Developmental Disabilities·J R ZarconeM F Dorsey
Jan 1, 1991·Research in Developmental Disabilities·L S Freund, A L Reiss
Mar 1, 1991·Journal of Autism and Developmental Disorders·J Rojahn, W J Helsel
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·A A Baumeister, J A Sevin
Nov 1, 1989·Archives of General Psychiatry·W K GoodmanD S Charney
Nov 1, 1989·Archives of General Psychiatry·W K GoodmanD S Charney
Nov 1, 1988·Journal of the American Academy of Child and Adolescent Psychiatry·M Aman
Jan 1, 1988·Research in Developmental Disabilities·J L MatsonW J Helsel
Jan 1, 1987·Research in Developmental Disabilities·M G AmanA J White
Jan 1, 1986·The American Journal of Psychiatry·S C YudofskyD Williams
Jan 1, 1986·Journal of the American Academy of Child Psychiatry·B J FreemanA Ritvo
Sep 1, 1983·Archives of General Psychiatry·D V Cicchetti, B A Prusoff
Jul 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·M G Aman, P L Wolford
Feb 1, 1995·The British Journal of Clinical Psychology·J A SevinS Kirkpatrick-Sanchez
Feb 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·E Spina, A P Caputi
Jan 1, 1994·Journal of Applied Behavior Analysis·B A IwataG S Richman
May 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·J P KemphR L Miller
Jan 1, 1996·Research in Developmental Disabilities·M G AmanD Hammer
Jun 1, 1996·Journal of Intellectual Disability Research : JIDR·W Meins
May 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·C J McDougleD J Cohen
Apr 1, 1997·Journal of Applied Behavior Analysis·K H KayserE A Stoner
Aug 1, 1997·Journal of Intellectual Disability Research : JIDR·S Reiss
Oct 17, 1998·European Journal of Clinical Pharmacology·A Alvarez-RequejoL H Arias
Nov 14, 1998·Journal of Learning Disabilities·J B HaleB Trommer
Dec 4, 1998·Research in Developmental Disabilities·J L MatsonC S Baglio
Feb 15, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·H DormannG Geisslinger
Sep 13, 2000·Research in Developmental Disabilities·J L MatsonJ R Logan
Oct 6, 2000·Clinical Pharmacokinetics·G Cheymol
Apr 11, 2001·Journal of Clinical Child Psychology·F R Volkmar
Oct 3, 2001·Pediatrics·UNKNOWN American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvemen
Jun 19, 2002·American Journal of Mental Retardation : AJMR·David B McAdamStephen R Schroeder

❮ Previous
Next ❯

Citations

Aug 4, 2010·Journal of Autism and Developmental Disorders·Bryan JepsonMichael S Allen
Oct 14, 2009·BMC Neurology·Jose-Ramon RuedaMaria-Isabel Tejada
Jul 12, 2011·American Journal on Intellectual and Developmental Disabilities·Andrea B CourtemancheJan B Sheldon
Dec 17, 2009·Developmental Disabilities Research Reviews·Scott S Hall
Apr 18, 2015·Journal of Applied Research in Intellectual Disabilities : JARID·Arlette ScheifesEibert R Heerdink
May 16, 2014·Journal of Applied Research in Intellectual Disabilities : JARID·Raistrick W Turton
May 3, 2014·Journal of Clinical Pharmacology·Andrew M HeitzerMaria G Valdovinos
May 6, 2020·Journal of Applied Research in Intellectual Disabilities : JARID·Lars-Olov LundqvistGerd Ahlström
Aug 25, 2021·American Journal on Intellectual and Developmental Disabilities·Blair P LloydAngela C Maxwell-Horn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved